(Osaka, Japan), Santen Pharmaceutical Co., Ltd
Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method
Therefore, remote GLP-1 therapy monitoring requires accurate baseline assessments, including A1C levels, renal function, and weight history
No clinically significant abnormalities in ECGs, vital signs, or physical examinations were detected
Acylcarnitine esters profiling of serum and follicular fluid in patients undergoing in vitro fertilization
Oral glutathione largely fails because it breaks down in the gut before reaching circulation